Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney

This publication has 26 references indexed in Scilit:

• Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism
  Molecular Pharmacology, 2003
• Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir Exhibit Multiple-Log Enhancement of Antiviral Activity against Cytomegalovirus and Herpesvirus Replication In Vitro
  Antimicrobial Agents and Chemotherapy, 2002
• Cidofovir in the treatment of poxvirus infections
  Antiviral Research, 2002
• Synthesis and Antiviral Evaluation of 1-O-Hexadecylpropanediol-3-P-acyclovir: Efficacy Against HSV-1 Infection in Mice
  Nucleosides, Nucleotides and Nucleic Acids, 2000
• Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus Challenge
  The Journal of Infectious Diseases, 2000
• Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir
  Clinical Pharmacokinetics, 1999
• The threat of bioterrorism returns the fear of smallpox
  Current Opinion in Microbiology, 1998
• Alkylthioglycerol Prodrugs of Foscarnet: Synthesis, Oral Bioavailability and Structure–Activity Studies in Human Cytomegalovirus-, Herpes Simplex Virus Type 1- and Human Immunodeficiency Virus Type 1-Infected Cells
  Antiviral Chemistry and Chemotherapy, 1998
• Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylemthoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γ
  Biochemical Pharmacology, 1994
• Efficacy of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice
  Journal of Medical Virology, 1993